Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Child and Adolescent Psychiatry

Total Results:

11540


Informativeness of Self-Reports of ADHD Symptoms in Monitoring Response to Stimulant Treatment in Clinically Referred Adults With ADHD

Biederman, Joseph; Fitzgerald, Maura; Spencer, Thomas J; Adler, Lenard A; Abrams, Jessica; Biederman, Itai; Faraone, Stephen V
OBJECTIVE:To investigate the informativeness of self-reports of ADHD symptoms in adults with ADHD in the clinical setting. METHOD/METHODS:Subjects were clinically referred adults aged 19 years to 67 years of age of both sexes ( N = 54). All subjects were on stable doses of stimulant and were considered responders to treatment. ADHD symptoms were assessed using the ADHD Investigator Symptom Rating Scale (AISRS) and the ADHD Self-Report Scale (ASRS). Spearman's rank correlations were used to assess the correlations between clinician-assessed ADHD and patients' self-reports. RESULTS:Spearman's rank correlation analysis found evidence of a strong, positive association between total scores on the AISRS and the ASRS ( rs = .65, df = 52, p< .001). CONCLUSION/CONCLUSIONS:Results have important implications for the management and monitoring of treatment response in the clinical setting through patients' self-report.
PMID: 29804496
ISSN: 1557-1246
CID: 3136792

Perceptual and Executive Behavioral Deficits in ADHD and Their Differential Correlation With Microsaccade Rate [Meeting Abstract]

Mihali, Andra; Young, Allison G.; Adler, Lenard A.; Halassa, Michael; Ma, Wei Ji
ISI:000432466300500
ISSN: 0006-3223
CID: 3147712

β-Adrenergic enhancement of neuronal excitability in the lateral amygdala is developmentally gated

Fink, Ann E; LeDoux, Joseph E
Noradrenergic signaling in the amygdala is important for processing threats and other emotionally salient stimuli, and β-adrenergic receptor activation is known to enhance neuronal spiking in the lateral amygdala (LA) of juvenile animals. Nevertheless, intracellular recordings have not yet been conducted to determine the effect of β-adrenergic receptor activation on spike properties in the adult LA, despite the potential significance of developmental changes between adolescence and adulthood. Here we demonstrate that the β-adrenergic agonist isoproterenol (15 μM) enhances spike frequency in dorsal LA principal neurons of juvenile male C57BL/6 mice and fails to do so in strain- and sex-matched adults. Furthermore, we find that the age-dependent effect of isoproterenol on spike frequency is occluded by the GABAA receptor blocker picrotoxin (75 μM), suggesting that β-adrenergic receptors downregulate tonic inhibition specifically in juvenile animals. These findings indicate a significant shift during adolescence in the cellular mechanisms of β-adrenergic modulation in the amygdala. NEW & NOTEWORTHY β-Adrenergic receptors (β-ARs) in amygdala are important in processing emotionally salient stimuli. Most cellular recordings have examined juvenile animals, while behavioral data are often obtained from adults. We replicate findings showing that β-ARs enhance spiking of principal cells in the lateral amygdala of juveniles, but we fail to find this in adults. These findings have notable scientific and clinical implications regarding the noradrenergic modulation of threat processing, alterations of which underlie fear and anxiety disorders.
PMCID:6008094
PMID: 29361666
ISSN: 1522-1598
CID: 3202482

Loudness Dependency of Auditory Evoked Potentials (LDAEP) as a Differential Predictor of Antidepressant Treatment Response in Major Depressive Disorder (MDD): Results From the Sertraline/Placebo-Controlled EMBARC Study [Meeting Abstract]

Kayser, Jurgen; Tenke, Craig E.; Petkova, Eva; Wong, Lidia Y. X.; Wickramaratne, Priya; Alschuler, Daniel M.; Alvarenga, Jorge E.; Abraham, Karen; Pechtel, Pia; Webb, Christian A.; Dillon, Daniel G.; Deldin, Patricia; Cooper, Crystal; Trombello, Joseph; McGrath, Patrick; Fava, Maurizio; Oquendo, Maria A.; Trivedi, Madhukar H.; Weissman, Myrna M.; Pizzagalli, Diego A.; Bruder, Gerard E.
ISI:000433001900381
ISSN: 0006-3223
CID: 3140402

Racial, Ethnic, and Gender Disparities in Health Care Access and Use Among U.S. Adults With Serious Psychological Distress

Weissman, Judith; Russell, David; Jay, Melanie; Malaspina, Dolores
OBJECTIVE:This study compared health care access and utilization among adults with serious psychological distress by race-ethnicity and gender in years surrounding implementation of the Affordable Care Act. METHODS:Data for adults ages 18 to 64 with serious psychological distress in the 2006-2015 National Health Interview Survey (N=8,940) were analyzed by race-ethnicity and gender on access and utilization indicators: health insurance coverage, insufficient money to buy medications, delay in health care, insufficient money for health care, visited a doctor more than ten times in the past 12 months, change in place of health care, change in place of health care because of insurance, saw a mental health provider in the past 12 months, and insufficient money for mental health care. RESULTS:The proportions of white and black adults with serious psychological distress were largest in the South, the region with the largest proportion of persons with serious psychological distress and no health coverage. Multivariate models that adjusted for health coverage, sociodemographic characteristics, health conditions, region, and year indicated that whites were more likely than blacks to report insufficient money for medications and mental health care and delays in care. A greater proportion of whites used private coverage, compared with blacks and Hispanics, and blacks were more likely than all other racial-ethnic groups to have Medicaid. CONCLUSIONS:More research is needed on health care utilization among adults with serious psychological distress. In this group, whites and those with private coverage reported poor utilization, compared with other racial-ethnic groups and those with Medicaid, respectively.
PMID: 29385956
ISSN: 1557-9700
CID: 2933832

Evidence of Differential Changes in Cortical Thickness and Volume Between SSRI and Placebo Treated Patients With Major Depressive Disorder [Meeting Abstract]

Bartlett, Elizabeth; DeLorenzo, Christine; Sharma, Priya; Yang, Jie; Zhang, Mengru; Petkova, Eva; Weissman, Myrna; McGrath, Patrick; Fava, Maurizio; Ogden, Todd; Kurian, Benji; Malchow, Ashley; Cooper, Crystal; Trombello, Joseph; McInnis, Melvin; Adams, Phil; Oquendo, Maria; Pizzagalli, Diego; Trivedi, Madhukar; Parsey, Ramin
ISI:000432466300177
ISSN: 0006-3223
CID: 3147792

Neural Correlates of Intolerance of Uncertainty in Youth [Meeting Abstract]

DeSerisy, Mariah; Musial, Alec; Comer, Jonathon S.; Dimartino, Adriana; Roy, Amy K.
ISI:000432466300360
ISSN: 0006-3223
CID: 3147742

Dynamic Changes in Risky Decision-Making Predict Imminent Heroin Use in Opioid Users Studied Longitudinally Through the First Months of Treatment [Meeting Abstract]

Konova, Anna; Lopez-Guzman, Silvia; Urmanche, Adelya; Ross, Stephen; Louie, Kenway; Rotrosen, John; Glimcher, Paul
ISI:000432466300077
ISSN: 0006-3223
CID: 3147812

Thalamic contribution to odor-guided behavior in rats [Meeting Abstract]

Courtiol, Emmanuelle; Wilson, Donald A.
ISI:000431236000023
ISSN: 0379-864x
CID: 3113822

Development of White Matter Circuitry in Infants With Fragile X Syndrome

Swanson, Meghan R; Wolff, Jason J; Shen, Mark D; Styner, Martin; Estes, Annette; Gerig, Guido; McKinstry, Robert C; Botteron, Kelly N; Piven, Joseph; Hazlett, Heather C
Importance:Fragile X syndrome (FXS) is a genetic neurodevelopmental disorder and the most common inherited cause of intellectual disability in males. However, there are no published data on brain development in children with FXS during infancy. Objective:To characterize the development of white matter at ages 6, 12, and 24 months in infants with FXS compared with that of typically developing controls. Design, Setting, and Participants:Longitudinal behavioral and brain imaging data were collected at 1 or more time points from 27 infants with FXS and 73 typically developing controls between August 1, 2008, and June 14, 2016, at 2 academic medical centers. Infants in the control group had no first- or second-degree relatives with intellectual or psychiatric disorders, including FXS and autism spectrum disorder. Main Outcomes and Measures:Nineteen major white matter pathways were defined in common atlas space based on anatomically informed methods. Diffusion parameters, including fractional anisotropy, were compared between groups using linear mixed effects modeling. Fiber pathways showing group differences were subsequently examined in association with direct measures of verbal and nonverbal development. Results:There were significant differences in the development of 12 of 19 fiber tracts between the 27 infants with FXS (22 boys and 5 girls) and the 73 infants in the control group (46 boys and 27 girls), with lower fractional anisotropy in bilateral subcortical-frontal, occipital-temporal, temporal-frontal, and cerebellar-thalamic pathways, as well as 4 of 6 subdivisions of the corpus callosum. For all 12 of these pathways, there were significant main effects between groups but not for the interaction of age × group, indicating that lower fractional anisotropy was present and stable from age 6 months in infants with FXS. Lower fractional anisotropy values in the uncinate fasciculi were correlated with lower nonverbal developmental quotient in the FXS group (left uncinate, F = 10.06; false discovery rate-corrected P = .03; right uncinate, F = 21.8; P = .004). Conclusions and Relevance:The results substantiate in human infants the essential role of fragile X gene expression in the early development of white matter. The findings also suggest that the neurodevelopmental effects of FXS are well established at 6 months of age.
PMCID:6026861
PMID: 29617515
ISSN: 2168-6238
CID: 4942402